{"err":null,"data":[{"aliases":["1pethlad"],"categories":["psychedelic","tentative","research-chemical"],"dose_note":" NOTE: These doses are very tentative, and are based on the likelihood that the dosage profile will be similar to ETH-LAD.","formatted_aftereffects":{"_unit":"hours","value":"2-12"},"formatted_dose":{"Oral":{"Common":"60-100ug","Light":"30-60ug","Strong":"100-200ug+","Threshold":"20-30ug"}},"formatted_duration":{"_unit":"hours","value":"6-10"},"formatted_onset":{"_unit":"minutes","value":"15-90"},"name":"1p-eth-lad","pretty_name":"1P-ETH-LAD","properties":{"after-effects":"2-12 hours.","aliases":["1pethlad"],"categories":["psychedelic","tentative","research-chemical"],"dose":"Oral Threshold: 20-30ug Light: 30-60ug Common: 60-100ug Strong: 100-200ug+ | NOTE: These doses are very tentative, and are based on the likelihood that the dosage profile will be similar to ETH-LAD.","duration":"6-10 hours.","experiences":"https://erowid.org/experiences/subs/exp_1PETHLAD.shtml","onset":"15-90 minutes","summary":"A new psychedelic lysergamide which is suspected to be a prodrug of ETH-LAD, which could explain why the doses are very similar. Or it could be active on its own. Scientific studies would need to be written to understand, yet there are none."}}]}